Larvol Delta - Asher-Bio-to-Showcase-Continued-Progress-with-Lead-Program-AB248-and-Growing-Pipeline-of-PreciselyTargeted-Immunotherapies-at-AACR-Annual-Meeting-2022

AB821 - Asher Biotherap

AB248 - Asher Biotherap

https://www.businesswire.com/news/home/20220308005541/en/Asher-Bio-to-Showcase-Continued-Progress-with-Lead-Program-AB248-and-Growing-Pipeline-of-Precisely-Targeted-Immunotherapies-at-AACR-Annual-Meeting-2022

Mar 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next